Michael Pack worked as a medicinal chemist for six years in the pharmaceutical industry in North America. His work focused on high throughput methods of synthesis and purification, as well as the planning and synthesis of focused small-molecule libraries. During this time, he helped develop potential drugs for diseases such as cancer and diabetes. Michael is skilled in a variety of purification procedures and instrument usage, as well as chemical synthesis procedures. He also wrote numerous scientific reports on chemical procedures and the molecular biology of oncology during his time as a researcher. Leaving the lab bench, Michael undertook an MBA focused on biotechnology marketing and finance. He then worked as a consultant for two biotechnology firms. His worked involved pricing IND drugs through of variety of methods, including risk adjusted net present value models, and intellectual properties pricing. Michael has authored a number of patents for chemical synthesis of oncology drugs, and has edited many scientific manuscripts in a wide variety of fields. He joined the Edanz Group as an in-house senior editor in the Fukuoka office in 2012.